ARCHIVES

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

This article is from The Cancer Letter archive.

Vol. 15 No. 10 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

April 29, 2011

NCI Cooperative Group Trials Approved Last Month By CTEP

March 26, 2010

NIH “RFA Game” Defeats Purpose Of OAM, Advisor Says

September 30, 1994

New Treatment Approaches for Leukemias Emerging From Early Clinical Trials

December 31, 2004

In Brief: Maguire Wants Five Environmental Experts In Addition To Those On The Board

February 16, 1979

WETA Relents Will Air Documentary

April 10, 1987